Oral contraceptive use and depression among adolescents

Annals of epidemiology, 29, 46-51

DOI 10.1016/j.annepidem.2018.10.002 PMID 30674431 Source
Purpose

Depression is a prevalent health problem affecting U.S. women. Oral contraceptive pills (OCPs) are commonly used for pregnancy prevention, and evidence is mixed regarding any increased risk for incident depression among users, particularly adolescents.

Methods

We examined the relationship between OCP use and depressive disorders among female adolescents using validated, structured interview assessments in a general population sample of adolescents in the National Comorbidity Survey-Adolescent Supplement. Respondents were 4765 female adolescents with no history of pregnancy who reported current OCP use, lifetime OCP use, and age of OCP initiation. Lifetime and current depressive disorders, including major depressive disorder and depressive episodes, were assessed by lay interviewers.

Results

In logistic regression models adjusted for a range of confounders, there was no relationship between ever using OCPs and lifetime depressive disorder (OR 1.10, 95% CI 0.88-1.37), nor current use of OCPs and current depressive disorder (OR 0.82, 95% CI 0.50-1.35). Using survival analysis for age-of-onset data, we found that OCP use is not associated with an increased risk of depressive disorders.

Conclusions

In sum, use of OCPs in a general population sample of adolescents did not increase the risk of depressive disorders.

oral contraceptives depression adolescents, birth control pills mood teenage girls, hormonal contraception mental health risk, ocp use depressive disorders young women, contraceptive pill depression side effects, adolescent oral contraceptive psychological effects, birth control depression national study, hormonal birth control mood changes teens, contraceptive counseling depression risk, oral contraceptive safety mental health

McKetta, S., & Keyes, K. (2019). Oral contraceptive use and depression among adolescents. *Annals of epidemiology*, *29*, 46-51. https://doi.org/10.1016/j.annepidem.2018.10.002